Department of Radiotherapy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Cancer Hospital of Dalian University of Technology, No.44 Xiaoheyan Road, Dadong District, Shenyang, 110042, Liaoning Province, China.
School of Graduate, Dalian Medical University, Dalian, 116044, China.
Mol Cancer. 2023 Jun 15;22(1):96. doi: 10.1186/s12943-023-01801-2.
BACKGROUND: Cancer is the most prevalent cause of death globally, and radiotherapy is considered the standard of care for most solid tumors, including lung, breast, esophageal, and colorectal cancers and glioblastoma. Resistance to radiation can lead to local treatment failure and even cancer recurrence. MAIN BODY: In this review, we have extensively discussed several crucial aspects that cause resistance of cancer to radiation therapy, including radiation-induced DNA damage repair, cell cycle arrest, apoptosis escape, abundance of cancer stem cells, modification of cancer cells and their microenvironment, presence of exosomal and non-coding RNA, metabolic reprogramming, and ferroptosis. We aim to focus on the molecular mechanisms of cancer radiotherapy resistance in relation to these aspects and to discuss possible targets to improve treatment outcomes. CONCLUSIONS: Studying the molecular mechanisms responsible for radiotherapy resistance and its interactions with the tumor environment will help improve cancer responses to radiotherapy. Our review provides a foundation to identify and overcome the obstacles to effective radiotherapy.
背景:癌症是全球最主要的死亡原因,放疗被认为是大多数实体瘤(包括肺癌、乳腺癌、食管癌、结直肠癌和胶质母细胞瘤)的标准治疗方法。对放疗的抵抗会导致局部治疗失败,甚至癌症复发。
主体:在这篇综述中,我们广泛讨论了导致癌症对放射治疗产生抵抗的几个关键方面,包括辐射诱导的 DNA 损伤修复、细胞周期阻滞、细胞凋亡逃逸、肿瘤干细胞的丰度、癌细胞及其微环境的修饰、外泌体和非编码 RNA 的存在、代谢重编程和铁死亡。我们的目的是集中讨论与这些方面相关的癌症放射治疗抵抗的分子机制,并讨论改善治疗效果的可能靶点。
结论:研究放疗抵抗的分子机制及其与肿瘤环境的相互作用将有助于提高癌症对放疗的反应。我们的综述为识别和克服有效放疗的障碍提供了基础。
Mol Cancer. 2023-6-15
J Cancer Res Clin Oncol. 2022-5
World J Gastroenterol. 2020-4-21
Front Oncol. 2023-8-22
Radiother Oncol. 2019-1-17
Adv Exp Med Biol. 2016
Semin Cancer Biol. 2022-11
Mater Today Bio. 2025-8-13
J Nanobiotechnology. 2025-8-29
Curr Issues Mol Biol. 2025-7-24
Clin Exp Metastasis. 2025-8-13
CA Cancer J Clin. 2023-1
Nat Rev Immunol. 2023-6
Signal Transduct Target Ther. 2022-10-17
Trends Cancer. 2022-11